ACTR707
Showing 1 - 3 of 3
Lymphoma Trial in United States (ACTR707, rituximab)
Terminated
- Lymphoma
- ACTR707
- rituximab
-
Gilbert, Arizona
- +10 more
Oct 4, 2021
Solid Tumor, HER-2 Protein Overexpression Trial in United States (ACTR T Cell Product, Trastuzumab)
Terminated
- Solid Tumor
- HER-2 Protein Overexpression
- ACTR T Cell Product
- Trastuzumab
-
New Haven, Connecticut
- +5 more
Mar 27, 2020